Back to search results
Collin Blakely
4.9 out of 5 (87)
Collin Blakely

Collin Blakely, MD, PHD

Thoracic Medical Oncology

(415) 885-3882
4.9 out of 5 (87)
Virtual visits available
4.9 out of 5 (87)
Virtual visits available
(415) 885-3882

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments.

Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF.

  • Board Certifications

    American Board of Internal Medicine, Medical Oncology, 2013

  • Fellowships

    UCSF, Medical Oncology & Hematology, 2011

  • Residencies

    Hospital of the University of Pennsylvania, Internal Medicine, 2009

  • Internship

    Hospital of the University of Pennsylvania, Internal Medicine, 2008

  • Degree

    Perelman School of Medicine at the University of Pennsylvania, 2007

  • Languages

    English

My approach is to learn from every patient and to continually push the envelope in the development of new treatments.

Conditions I specialize in

My reviews

4.9

Overall Experience
87 Ratings
About our process
Jun 18, 2025
Dr Blakely is an excellent Dr in all ways.
Jun 04, 2025
Dr. Blakely was very kind, knowledgeable and did a good job explaining my situation and possible treatments.
Jun 04, 2025
I Love Dr. Blakely!!
May 29, 2025
Fully satisfied
May 07, 2025
Dr. Blakely is top notch. I hope we can continue our annual follow ups
May 01, 2025
Dr Blakely was very thorough in explaining the treatment options to me.
Mar 14, 2025
I feel very blessed to have Dr. Blakeley as my Care Provider. I trust him with my care. I appreciate his professionalism, knowledge, and experience, and I am so very grateful that he is my Care Provider. Thank you.
Sep 18, 2024
Dr. Blakely and his team are excellent. He is knowledgeable, expert in his field, caring, easy to understand-I am so fortunate to be in his expert care.
May 10, 2024
Tried to be empathetic and was pretty good.
Jan 03, 2024
Dr. Blakely took the time to answer my questions and the visit was not rushed in any way.
Nov 22, 2023
Satisfied
Nov 17, 2023
He listened to and asked about how I was doing.
Oct 25, 2023
Very pleased with him
Oct 18, 2023
Everyone I dealt with there were top notch professionals. I can't think of anything that could be improved.
Sep 15, 2023
Dr. Blakely and his team are excellent! He is caring, informative, provides suggestions, etc., etc. His follow up is excellent as well! I am so very blessed and thankful to have him as my oncologist!!
Aug 25, 2023
I would prefer in an in-office appointment. I've never seen Dr. Blakely face to face or have had the benefit of faving him go over images with me.

Selected research

See all research
Decorative Caduceus

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Partic...

PFS is defined as the time from randomization to the first occurrence of disease progression, as determined by blinded independent central review (BICR) according to RECIST v1.1, or death from any cause (whichever occurs first)

Recruiting

Decorative Caduceus

A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-...

MPR is defined as </=10% residual viable tumor cells as scored by local pathologists

Recruiting

Decorative Caduceus

Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

The MTD is the highest dose at which no more than one instance of a dose-limiting toxicity is observed among the 6 participants treated.

Recruiting

Contact me

Share